Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting

Denver, Colorado 27 January 2025 - 01 February 2025

APOSTEL 8: Tocolytic benefit for threatened preterm birth called into question

01 Mar 2025 bởi

In the management of threatened preterm birth between 30 and 34 weeks of gestation, atosiban falls short of improving neonatal outcomes when compared with placebo, according to the results of the APOSTEL 8 trial.

APOSTEL 8: Tocolytic benefit for threatened preterm birth called into question

01 Mar 2025

Severe maternal morbidity up by fourfold in presence of CRC

27 Feb 2025 bởi

Pregnant women with colorectal cancer (CRC) face a considerably increased likelihood of severe maternal morbidity, including disseminated intravascular coagulation, acute respiratory distress syndrome, and hysterectomy, among others, according to a study.

Severe maternal morbidity up by fourfold in presence of CRC

27 Feb 2025

Aspirin for preeclampsia prophylaxis: Does dose matter?

27 Feb 2025 bởi

Doubling up on the daily aspirin dose of 81 mg appears to yield no significant protective effect against the incidence of preeclampsia in high-risk pregnancies, suggests findings from the ASAPP* study presented at SMFM 2025.

Aspirin for preeclampsia prophylaxis: Does dose matter?

27 Feb 2025

Antenatal corticosteroid reduces neonatal morbidities in late preterm twins

25 Feb 2025 bởi

Antenatal corticosteroid betamethasone administration significantly reduces the risk of neonatal respiratory morbidity in women with twin pregnancies at risk of late preterm delivery, according to the ACTWIN* trial presented at SMFM 2025.

Antenatal corticosteroid reduces neonatal morbidities in late preterm twins

25 Feb 2025

Breastfeeding protects women against postpartum CVD

20 Feb 2025 bởi

Women who breastfeed, especially those with prior gestational diabetes mellitus (GDM), appear to have greater protection against long-term atherosclerotic cardiovascular disease (ASCVD), suggest the results of a study presented at SMFM 2025.

Breastfeeding protects women against postpartum CVD

20 Feb 2025

Postpartum diuretics use eases persistent hypertension

20 Feb 2025 bởi

The postpartum use of diuretics can reduce persistent hypertension in women with hypertensive disorders of pregnancy (HDP), according to the results of a systematic review and meta-analysis presented at SMFM 2025.

Postpartum diuretics use eases persistent hypertension

20 Feb 2025

Single-dose IV iron may be effective first-line treatment for maternal IDA

19 Feb 2025 bởi

Administration of single-dose intravenous (IV) iron during the early second trimester of pregnancy reduced the incidence of low birth weight (LBW) infants and achieved nonanaemic status (NAS) at delivery, according to a study presented at SMFM 2025.

Single-dose IV iron may be effective first-line treatment for maternal IDA

19 Feb 2025

Studies support nifedipine for postpartum hypertension management

14 Feb 2025 bởi

Data presented at SMFM 2025 favour nifedipine over labetalol for the management of hypertension in the postpartum period.

Studies support nifedipine for postpartum hypertension management

14 Feb 2025